Brain training gets a boost: drug aims to sharpen minds in schizophrenia
NCT ID NCT04857983
Summary
This study tested if adding a drug called memantine to a brain training program could help people with schizophrenia or schizoaffective disorder. Researchers wanted to see if this combination could improve thinking skills, reduce symptoms, and help with daily activities better than brain training alone. The trial involved 62 adults who were already taking antipsychotic medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Teaching Facility (CTF B-403 at UCSD Medical Center)
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.